Indrayani Biotech Ltd Stock Price Today (NSE: INDRANIB)
Fundamental Score
Indrayani Biotech Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Indrayani Biotech Ltd share price today is ₹11.49, up +3.51% on NSE/BSE as of 23 June 2026. Indrayani Biotech Ltd (INDRANIB) is a Small-cap company in the Other Agricultural Products sector with a market capitalisation of ₹68.07 (Cr). The 52-week high for INDRANIB share price is ₹16.50 and the 52-week low is ₹6.10. The company has a Return on Equity (ROE) of -8.75% and a debt-to-equity ratio of 1.89.
Indrayani Biotech Ltd Share Price Chart — NSE/BSE Historical Performance
Indrayani Biotech Ltd share price chart: -15.50% return over the past month. 52-week high ₹16.50, 52-week low ₹6.10.
Indrayani Biotech Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹11.11 | ₹11.65 | ₹10.56 | ₹11.49 | 54.33K (Cr) | |
| ₹11.10 | ₹11.10 | ₹10.66 | ₹11.10 | 37.88K (Cr) | |
| ₹10.35 | ₹10.63 | ₹10.15 | ₹10.58 | 36.46K (Cr) | |
| ₹10.34 | ₹10.35 | ₹10.25 | ₹10.30 | 69.17K (Cr) | |
| ₹10.29 | ₹10.42 | ₹10.05 | ₹10.35 | 59.11K (Cr) | |
| ₹10.65 | ₹10.65 | ₹10.20 | ₹10.21 | 74.47K (Cr) | |
| ₹10.40 | ₹10.54 | ₹10.36 | ₹10.43 | 88.63K (Cr) | |
| ₹10.38 | ₹10.68 | ₹10.38 | ₹10.42 | 40.18K (Cr) | |
| ₹10.30 | ₹10.83 | ₹10.30 | ₹10.38 | 20.44K (Cr) | |
| ₹10.52 | ₹10.87 | ₹10.52 | ₹10.69 | 45.58K (Cr) |
Indrayani Biotech Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹11.10 | ₹11.65 | ₹10.56 | ₹11.49 | +3.51% | |
| ₹11.90 | ₹11.93 | ₹10.05 | ₹10.58 | -11.09% | |
| ₹7.20 | ₹12.90 | ₹7.09 | ₹11.70 | +62.50% | |
| ₹8.00 | ₹9.19 | ₹6.10 | ₹7.23 | -9.62% | |
| ₹9.50 | ₹9.70 | ₹7.73 | ₹8.08 | -14.95% | |
| ₹11.69 | ₹11.99 | ₹8.56 | ₹9.58 | -18.05% | |
| ₹14.51 | ₹15.15 | ₹10.85 | ₹11.31 | -22.05% | |
| ₹14.90 | ₹16.47 | ₹13.55 | ₹14.73 | -1.14% | |
| ₹12.61 | ₹16.47 | ₹10.80 | ₹14.12 | +11.97% | |
| ₹11.58 | ₹13.63 | ₹10.20 | ₹12.36 | +6.74% | |
| ₹14.00 | ₹15.95 | ₹11.20 | ₹11.58 | -17.29% | |
| ₹13.60 | ₹16.50 | ₹13.40 | ₹13.79 | +1.40% |
AI Research Briefing
Powered by Gemini · 2026-04-09
Micro-cap gamble on a turnaround narrative with a high probability of failure.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Indrayani Biotech faces increased scrutiny as the exchange sought clarification on significant price movement on April 8, 2026. A rights issue committee meeting is scheduled for April 9, 2026, to finalize key parameters of the upcoming rights issue, including issue size and subscription price. The board will also consider a demerger proposal on the same day.
CORE STORY (THE REAL GAME)
Indrayani Biotech is attempting a turnaround narrative via capital raise (rights issue) and potential restructuring (demerger). The market is focused on whether these actions can address the company's weak financial performance and high debt.
- Rights issue committee meeting on April 9, 2026
- Exchange seeking clarification on price movement
- Board to consider demerger proposal
- Favorable terms for the rights issue
- Value-unlocking demerger
- Significant order wins
- Micro/SME cap - liquidity risk
- Negative ROE and ROCE
- High Debt/Equity ratio of 1.89
- Negative Interest Coverage of -3.07x
- Promoter holding is low at 33.26%
- Received SARFAESI notice from Hinduja Leyland Finance Limited regarding NPA classification
Promoter holding slightly decreased by 0.02%.
Agricultural exports from India are expected to grow significantly in 2026, but Indrayani Biotech's specific positioning is unclear.
No major news found after live search.
No. Free Cash Flow 5Y: ₹-52.5 Cr
Company needs to successfully execute rights issue and demerger to improve financials. 3-6 month outlook is highly uncertain.
Primary Thesis Risk
Inability to service debt will lead to collapse.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Indrayani Biotech Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Indrayani Biotech Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of INDRANIB across key market metrics for learning purposes.
Positive Indicators
1 factors identified
Consistent Growth Track Record (21.21% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Risk Factors
9 factors identified
Below-Average Return on Equity (-8.75%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-1.12%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Profit Decline Concern (-81.18%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-7.71%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Elevated Debt Levels (D/E: 1.89)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.
Weak Interest Coverage (-3.07x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-52.50 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 3.13%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Indrayani Biotech Ltd vs Other Agricultural Products Peers
Peer Comparison - Other Agricultural Products
Compare Indrayani Biotech Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Indrayani Biotech LtdIndrayani Biote...Selected✓ INDRANIB • 526445 | 2.6/100 | ₹11.49₹11 | ₹68.07₹68.07 | — — | -8.75%Poor -8.75% Poor | -1.12%Poor -1.12% Poor | 1.89Average 1.9 Average | — — | 21.21%Excellent 21.21% Excellent | 0.00% |
LT Foods LtdLT Foods Ltd... LTFOODS • 532783 | 67.8/100 | ₹404.70₹405 | ₹14419.68₹14419.68 | 22.67Average 22.7 Average | 16.70%Good 16.70% Good | 19.18%Good 19.18% Good | 0.43Excellent 0.4 Excellent | 26.37%Excellent 26.37% Excellent | 15.99%Excellent 15.99% Excellent | 0.72% |
KRBL LtdKRBL Ltd... KRBL • 530813 | 54.6/100 | ₹360.25₹360 | ₹9182.57₹9182.57 | 15.07Average 15.1 Average | 9.42%Poor 9.42% Poor | 11.84%Average 11.84% Average | 0.01Excellent 0.0 Excellent | -3.15%Poor -3.15% Poor | 4.45%Average 4.45% Average | 0.87% |
Gujarat Ambuja Exports LtdGujarat Ambuja ... GAEL • 524226 | 44.1/100 | ₹160.47₹160 | ₹5195.38₹5195.38 | 25.18Average 25.2 Average | 8.59%Poor 8.59% Poor | 11.46%Average 11.46% Average | 0.09Excellent 0.1 Excellent | 10.42%Good 10.42% Good | 3.86%Average 3.86% Average | 0.22% |
Kaveri Seed Company LimitedKaveri Seed Com... KSCL • 532899 | 56.1/100 | ₹899.70₹900 | ₹5132.36₹5132.36 | 16.93Average 16.9 Average | 19.04%Good 19.04% Good | 20.08%Excellent 20.08% Excellent | 0.00Excellent 0.0 Excellent | 3.36%Average 3.36% Average | 5.30%Good 5.30% Good | 0.50% |
Grm Overseas LtdGrm Overseas Lt... GRMOVER • 531449 | 48.3/100 | ₹158.32₹158 | ₹2915.20₹2915.20 | 42.95Average 43.0 Average | 16.03%Good 16.03% Good | 13.50%Average 13.50% Average | 0.44Excellent 0.4 Excellent | 13.84%Good 13.84% Good | 12.44%Good 12.44% Good | 0.00% |
Sanstar LtdSanstar Ltd... SANSTAR • 544217 | 45.7/100 | ₹115.24₹115 | ₹1641.27₹1641.27 | 81.74Average 81.7 Average | 9.63%Poor 9.63% Poor | 11.76%Average 11.76% Average | 0.03Excellent 0.0 Excellent | 129.68%Excellent 129.68% Excellent | 29.55%Excellent 29.55% Excellent | 0.00% |
Chaman Lal Setia Exp LtdChaman Lal Seti... CLSEL • 530307 | 42.3/100 | ₹279.90₹280 | ₹1277.19₹1277.19 | 13.57Average 13.6 Average | 14.19%Average 14.19% Average | 16.71%Good 16.71% Good | 0.09Excellent 0.1 Excellent | 14.42%Good 14.42% Good | 13.39%Good 13.39% Good | 0.97% |
52.7/100 | ₹97.53₹98 | ₹1096.07₹1096.07 | 39.53Average 39.5 Average | 28.81%Excellent 28.81% Excellent | 21.16%Excellent 21.16% Excellent | 0.25Excellent 0.3 Excellent | 58.19%Excellent 58.19% Excellent | 28.28%Excellent 28.28% Excellent | 0.00% | |
Avt Natural Products LtdAvt Natural Pro... AVTNPL • 519105 | 57.2/100 | ₹68.64₹69 | ₹1038.52₹1038.52 | 16.92Average 16.9 Average | 9.89%Poor 9.89% Poor | 12.84%Average 12.84% Average | 0.19Excellent 0.2 Excellent | 7.46%Good 7.46% Good | 7.00%Good 7.00% Good | 1.03% |
Gulshan Polyols LtdGulshan Polyols... GULPOLY • 532457 | 45.7/100 | ₹178.47₹178 | ₹838.46₹838.46 | 19.65Average 19.6 Average | 3.92%Poor 3.92% Poor | 6.31%Poor 6.31% Poor | 0.70Good 0.7 Good | 2.79%Average 2.79% Average | 26.61%Excellent 26.61% Excellent | 0.22% |
Top Other Agricultural Products Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- LT Foods Ltd share price14419.68 Cr
- KRBL Ltd share price9182.57 Cr
- Gujarat Ambuja Exports Ltd share price5195.38 Cr
- Kaveri Seed Company Limited share price5132.36 Cr
- Grm Overseas Ltd share price2915.20 Cr
Indrayani Biotech Ltd PE Ratio History
Historical price-to-earnings ratio for INDRANIB — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹1.40 | ₹36.24 | 25.9x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Indrayani Biotech Ltd Quarterly Performance
Latest quarterly metrics for INDRANIB — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-7.71%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-81.18%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
21.21%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Indrayani Biotech Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for INDRANIB — calculated from daily price history
Selling pressure is heavy — potential reversal zone.
Technical indicators are for educational purposes only. Not investment advice.
Indrayani Biotech Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Indrayani Biotech Ltd (INDRANIB) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Indrayani Biotech Ltd
About INDRANIB (Indrayani Biotech Ltd)
Indrayani Biotech Ltd is a pioneering force in the realm of agricultural innovation, focusing on the development and distribution of specialized products designed to enhance crop y...ields and promote sustainable farming practices. With a commitment to harnessing the power of biotechnology, the company cultivates solutions tailored to address the evolving needs of modern agriculture. Their core focus lies in creating advanced bio-stimulants, organic fertilizers, and specialized soil amendments, all rigorously tested and formulated to optimize plant health, improve nutrient uptake, and enhance resistance to environmental stresses. Indrayani Biotech strives to empower farmers with the tools necessary to cultivate thriving, resilient crops while minimizing the environmental impact of agricultural practices. The company's product portfolio extends beyond conventional agricultural inputs, encompassing a range of cutting-edge solutions for crop protection and enhancement. Indrayani Biotech is dedicated to developing and manufacturing innovative bio-pesticides and bio-fungicides, providing effective and environmentally responsible alternatives to traditional chemical treatments. These products are designed to target specific pests and diseases while preserving beneficial insect populations and minimizing the risk of soil contamination. Furthermore, the company invests in research and development to explore new avenues for improving crop resilience, including the development of drought-tolerant varieties and bio-fortified crops that offer enhanced nutritional value. Indrayani Biotech operates with a deep-seated commitment to sustainability and ethical sourcing, ensuring that its products are manufactured with minimal environmental impact and that its practices align with the principles of responsible agriculture. The company actively collaborates with farmers and agricultural experts to develop customized solutions tailored to specific regional needs and environmental conditions. Through comprehensive training programs and educational initiatives, Indrayani Biotech empowers farmers with the knowledge and resources necessary to implement sustainable farming practices and maximize the benefits of its innovative products. With a vision for a healthier, more sustainable future, Indrayani Biotech is dedicated to transforming the agricultural landscape through the power of biotechnology.
Company Details
Key Leadership
INDRANIB Share Price: Frequently Asked Questions
What is the current share price of Indrayani Biotech Ltd?
Indrayani Biotech Ltd (INDRANIB) trades at ₹11.49 on NSE and BSE. Market cap ₹68.07 (Cr). Educational data only.
What is the P/E ratio of Indrayani Biotech Ltd?
Indrayani Biotech Ltd has a P/E of N/Ax vs industry average 21.07x.
What is the Bull Run score for Indrayani Biotech Ltd?
Indrayani Biotech Ltd has a Bull Run score of 2.6/100 based on 25+ financial parameters.
Does Indrayani Biotech Ltd pay dividends?
Indrayani Biotech Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Indrayani Biotech Ltd?
Indrayani Biotech Ltd has ROE of -8.75%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Indrayani Biotech Ltd?
Indrayani Biotech Ltd has debt-to-equity of 1.89.
Is Indrayani Biotech Ltd a good investment?
Bull Run gives Indrayani Biotech Ltd a score of 2.6/100. This is not investment advice — consult a SEBI-registered advisor.